Hims & Hers Falls, Kroger Rises, Monday.com Sinks on Weak Forecast

Stock Movers

On this episode of Stock Movers:

- Hims & Hers (HIMS) shares fall on news that Novo Nordisk is suing the company for making knock-offs of its obesity medicines, including a copycat version of the Wegovy pill. The lawsuit targets not only Hims's copycat pill but also shots that mimic Novo's Wegovy and Ozempic, with Novo arguing that Hims's products are putting patient health and wellbeing at risk.

- Kroger (KR) shares rise after the company named Greg Foran its chief executive officer as the nation’s largest supermarket operator seeks to reset after a failed mega-merger and the sudden exit of its former leader.

- Monday.com (MNDY) shares sink after the software company’s revenue forecast was weaker than expected. According to Bloomberg Intelligence: Monday.com's below-consensus 2026 outlook reinforces our caution around seat-based business models amid slower AI-feature monetization, a shift toward agentic workflows and newer product rollouts from foundational model providers that increase the risk of disintermediation.

See omnystudio.com/listener for privacy information.

More description

On this episode of Stock Movers:

- Hims & Hers (HIMS) shares fall on news that Novo Nordisk is suing the company for making knock-offs of its obesity medicines, including a copycat version of the Wegovy pill. The lawsuit targets not only Hims's copycat pill but also shots that mimic Novo's Wegovy and Ozempic, with Novo arguing that Hims's products are putting patient health and wellbeing at risk.

- Kroger (KR) shares rise after the company named Greg Foran its chief executive officer as the nation’s largest supermarket operator seeks to reset after a failed mega-merger and the sudden exit of its former leader.

- Monday.com (MNDY) shares sink after the software company’s revenue forecast was weaker than expected. According to Bloomberg Intelligence: Monday.com's below-consensus 2026 outlook reinforces our caution around seat-based business models amid slower AI-feature monetization, a shift toward agentic workflows and newer product rollouts from foundational model providers that increase the risk of disintermediation.

See omnystudio.com/listener for privacy information.

2026-02-09 2 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.